1st April, the UK medicines regulator has issued guidance for industry on regulatory flexibilities that apply to the production of medicines in the UK.
The Link is here (this link also links to other relevant guidance)
The regulatory flexibilities are too lengthy and complex to summarise here in this Blog. The reader is asked to use the Link and read the relevant sections.
The Chancellor has also waived import duties and VAT on medical imports – here.